Influence of smart phone application based intervention on medication adherence in patients with chronic diseases-A Randomized controlled trial.

JIPMER Puducherry0 个研究点目标入组 0 人开始时间: 待定最近更新: 2021年11月24日

试验速览

暂无简介。

•Diabetes mellitus and Systemic hypertension:
•1. Patients with type 2 diabetes (T2DM) aged greater than 18years irrespective of gender, who are on stable dose of anti-diabetic medication for at least 1 month
•2. Patients with Systemic hypertension aged greater than 18years irrespective of gender, who are on stable dose of antihypertensive medication for at least 1 month
•3. Patients with concomitant type 2 diabetes and systemic hypertension
•4. Patients who are able to read Tamil/ English/ Hindi
•5. Patients who are owning and operating a smartphone at least for 3 months
•6. Patients who are using the smartphone daily, having the phone within reach and checking it atleast three times a day
•7. Patients who have not used any medication adherence application till now
•8. Patients with gastro-intestinal malignancies receiving capecitabine
•9. Patients with chronic myeloid leukemia receiving imatinib
•10. Patients with breast cancer receiving hormonal therapy (tamoxifen)
•11. Patients with lung cancer receiving gefitinib
•12. Patients with Acute lymphoid leukemia receiving methotrexate/ 6-mercaptopurine
•13. Patients who are able to read Tamil/ English/ Hindi
•14. Patients who are owning and operating a smartphone for at least 3 months
•15. Patients who are using the smartphone daily, having the phone within reach and checking it atleast three times a day
•16. Patients who have not used any medication adherence application till now

•Diabetes mellitus and Systemic hypertension:
•1. Diabetic patients on insulin therapy
•2. Patients with secondary hypertension or gestational hypertension
•3. Patients with hypertensive emergency/ urgency
•4. Pregnant or lactating women
•5. Patients with hepatic/ renal impairment
•6. Patients with h/o Coronary artery disease, cerebrovascular disease, stroke, Myocardial Infarction(MI) in the past 3 months
•7. Patients who had participated in any other trials in the past 3 months
•8. Patients with h/o surgery in the past 3 months or planning for surgery in the next 3 months
•9. Patients on herbal medications
•10. Pregnant or lactating women
•11. Patients with h/o surgery in the past 3 months or planning for surgery in the next 3 months
•12. Patients with hepatic/ renal impairment
•13. Patients with h/o Coronary artery disease, cerebrovascular disease, stroke, MI in the past 3 months
•14. Patients who had participated in any other trials in the past 3 months
•15. Patients on herbal medications

发起方